Tilos Therapeutics is involved in the development of therapeutics, which targets the latent TGFβ complex to treat cancer, fibrosis and autoimmune diseases. TGFβ is a potent cytokine supposed
The post Merck to buy biopharmaceutical firm Tilos Therapeutics in £608m deal appeared first on Pharmaceutical Business review.
Original Article: Merck to buy biopharmaceutical firm Tilos Therapeutics in £608m deal